Skip to main content
Clinical Trials/NCT06353165
NCT06353165
Completed
Phase 3

A Clinical Study to Investigate Stannous Fluoride Toothpaste on Antibacterial Effects in the Different Regions of the Mouth as Compared to Colgate Cavity Protection Toothpaste

Colgate Palmolive1 site in 1 country100 target enrollmentMarch 8, 2023

Overview

Phase
Phase 3
Intervention
Colgate Dental Cream
Conditions
Plaque, Dental
Sponsor
Colgate Palmolive
Enrollment
100
Locations
1
Primary Endpoint
Measurement of total bacterial counts in saliva
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This 4-week clinical study was designed to examine the antibacterial efficacy of brushing with a 0.454% stannous fluoride toothpaste with potassium nitrate and pyrophosphate compared to a toothpaste containing 0.76% MFP (marketed as Colgate Cavity Protection Toothpaste) in different regions of the mouth (dental plaque, tongue, cheek, gum surface and in saliva) 12 hours post-brushing (overnight) after 2 and 4 weeks of product use.

Registry
clinicaltrials.gov
Start Date
March 8, 2023
End Date
April 12, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects, ages 18-70, inclusive.
  • Subject is available during study duration and has no allergies to oral hygiene formulations.
  • A minimum of 20 natural teeth with facial and lingual scorable surfaces.
  • A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them. Subject should demonstrate a willingness to comply with all study procedures and clinical examination schedules.
  • Subjects with a baseline whole mouth scores of dental plaque of 1.5 or more \[Turesky Modification of Quigley-Hein\] and gingivitis index of 1.0 or more \[Loe-Silness\].

Exclusion Criteria

  • Participation in any other clinical study or test panel including clinical studies with oral hygiene formulations within the one month prior to entry into the study.
  • History of dental prophylaxis or treatments in the past month or during study duration.
  • History of medical treatments including antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding study enrollment.
  • Subjects scheduled for medical procedures for the duration of the study.
  • Difficulty complying with study procedures and examinations such as excessive gagging during oral assessment etc.
  • History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthrinses. Allergy to personal care/consumer products or their ingredients.
  • History of diabetes or hepatic or renal disease, or medical or inflammatory conditions or transmittable diseases, e.g. heart disease or AIDS.
  • History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.
  • Oral soft tissue pathology.
  • History of active or severe periodontal disease and loose teeth.

Arms & Interventions

Group I

toothpaste brushing 2/day for 2 minutes

Intervention: Colgate Dental Cream

Group II

toothpaste brushing 2/day for 2 minutes

Intervention: Stannous fluoride toothpaste

Outcomes

Primary Outcomes

Measurement of total bacterial counts in saliva

Time Frame: baseline, 2 week & 4 week

Collected samples in saliva will be placed in sterile vials, labeled with subject information and transferred to the laboratory for analysis

Measurement of total bacterial counts on cheek

Time Frame: baseline, 2 week & 4 week

Scrapings from the surface of the cheek mucosa. All collected samples will be placed in sterile vials, labeled with subject information and transferred to the laboratory for analysis

Whole mouth scores of dental plaque

Time Frame: baseline, 2 week & 4 week

Measuring the dental plaque using the Turesky Modification of Quigley-Hein.Subjects presenting with whole mouth scores for dental plaque of 1.5 or more \[Turesky Modification of plaque will be enrolled. Quigley-Hein.

Measurement of total bacterial counts on tongue

Time Frame: baseline, 2 week & 4 week

Scrapings from the surface of the tongue. All collected samples will be placed in sterile vials, labeled with subject information and transferred to the laboratory for analysis

Measurement of gingivitis

Time Frame: baseline, 2 week & 4 week

Using the Loe-Silness index.Subjects presening will 1.0 or more for gingivitis \[Loe-Silness\] will be enrolled.

Study Sites (1)

Loading locations...

Similar Trials